About Dynakin
Dynakin is a Healthcare company based in Derio (Spain) founded in 2004, and was acquired by CTI Clinical Trial in July 2021. Translational drug development services are provided from pre-clinical to marketing. Dynakin offers products and services including DynaPred, Strategic Consulting, Bioanalytical Services, and Clinical Trial Services. Its focus areas include Biopharma Outsourcing, CRO and Diversified. Its legal entity is DYNAKIN S.L.
Company details
DynaKin was established in 2004 in Derio, Spain, within the pharmaceutical and biotechnology sector. Services encompass translational drug development from pre-clinical phases to marketing. Clinical research support is extended for product development across Phases I through IV. Bioanalytical services are delivered for both non-clinical and clinical programs. Optimization of drug development processes is facilitated through pharmaceutical statistical models.
- Headquarters Derio, Spain
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website dynakin.com
- Social LinkedIn
- Acquired by CTI Clinical Trial (Jul 2021)
- Legal Name Dynakin S.L.
- Investors
- Acquired byCTI Clinical Trial
(Jul 2021)
Products & Services of Dynakin
Dynakin offers a comprehensive portfolio of products and services, including DynaPred, Strategic Consulting, Bioanalytical Services, and Clinical Trial Services.
Platform for personalized pharmacotherapy in drug development processes.
Provides strategic advice for pharmaceutical and regulatory strategies.
Offers testing and methods for drug analysis in clinical settings.
Manages services for clinical trials and related research activities.
Investors in Dynakin
Dynakin has secured backing from 1 investor. Prominent investors backing the company include CTI Clinical Trial.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provides clinical trials, consulting, and regulatory services in healthcare sectors. | 1999 | ctifacts.com | Cincinnati, United States |
Investor details for Dynakin
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Dynakin
2 dated milestones of Dynakin across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Dynakin is founded.
- Exit Acquired by CTI Clinical Trial.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Dynakin
Dynakin was founded in 2004.
Dynakin is headquartered in Derio, Spain. It is registered at Derio, Pais Vasco, Spain.
DynaKin was established in 2004 in Derio, Spain, within the pharmaceutical and biotechnology sector. Services encompass translational drug development from pre-clinical phases to marketing. Clinical research support is extended for product development across Phases I through IV. Bioanalytical services are delivered for both non-clinical and clinical programs. Optimization of drug development processes is facilitated through pharmaceutical statistical models.
Dynakin offers DynaPred, Strategic Consulting, Bioanalytical Services, and Clinical Trial Services.
Dynakin has 1 investor. Key investors include CTI Clinical Trial.
Dynakin operates through Dynakin S.L..
Yes. Dynakin was acquired by CTI Clinical Trial in July 2021.